CAMBRIDGE, Mass.--(BUSINESS WIRE)--RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced the company’s CEO, Ronald Renaud, will present a corporate overview at the UBS Global Healthcare Conference at 3:00 p.m. ET on Monday, May 22. The conference will take place at the Grand Hyatt New York.
About RaNA Therapeutics
RaNA Therapeutics is a leading biotechnology company committed to the development of next generation RNA-targeted medicines. RaNA’s mission is to improve the lives of people suffering from serious life-altering diseases by creating precision medicines that can change the course of their condition. RaNA’s technology has broad therapeutic potential to treat a wide range of diseases, including rare genetic disorders. For more information about the company and its platforms, please visit www.ranarx.com.